Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60341-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- FGF18 antibody
- Antibody type
- Monoclonal
- Description
- FGF18 antibody (Cat. #60341-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse, rabbit and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rabbit
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D11D12
- Vial size
- 20ul, 150ul
Submitted references Bioinspired scaffold recapitulating chondrogenic ontogeny and microenvironment for functional cartilage regeneration.
Fibroblast growth factor 18 stimulates chondrocyte proliferation by modulating FOXN2 to mitigate post-traumatic osteoarthritis in a mouse model.
Transgenerational inheritance of diminished ovarian reserve triggered by prenatal propylparaben exposure in mice.
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.
Yu T, Sun X, Liu Y, Dou Y, Tian Y, Zhang Y, Wang G, Wang L, Han J, Li X, Cheng X, Li H, Pan H, Yang L, Zhao Y, Yang Q
Bioactive materials 2026 Apr;58:531-549
Bioactive materials 2026 Apr;58:531-549
Fibroblast growth factor 18 stimulates chondrocyte proliferation by modulating FOXN2 to mitigate post-traumatic osteoarthritis in a mouse model.
Huang Z, Zhao W, Lan J, Lin Y, Gao X
Frontiers in bioengineering and biotechnology 2025;13:1615124
Frontiers in bioengineering and biotechnology 2025;13:1615124
Transgenerational inheritance of diminished ovarian reserve triggered by prenatal propylparaben exposure in mice.
Li M, Wu Y, Wei S, Zhang T, Yan W, Gao Y, Chen Y, Hu D, Wu T, Li M, Wang W, Li Y, Zhou S, He X, Wang S, Zhang J
Nature communications 2025 Sep 16;16(1):8289
Nature communications 2025 Sep 16;16(1):8289
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.
Guo K, Ma Z, Zhang Y, Han L, Shao C, Feng Y, Gao F, Di S, Zhang Z, Zhang J, Tabbò F, Ekman S, Suda K, Cappuzzo F, Han J, Li X, Yan X
Journal of experimental & clinical cancer research : CR 2022 Mar 11;41(1):91
Journal of experimental & clinical cancer research : CR 2022 Mar 11;41(1):91
No comments: Submit comment
No validations: Submit validation data